1-5 of 5
Ki-Ryang Koh, MD, PhD
Close
Sort by
Journal Articles

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD, PhD, Hideo Koh, MD, Mika Nakamae, MD, PhD, Yoshiki Hayashi, MD, Mitsutaka Nishimoto, MD, Takuro Yoshimura, MD, Eri Inoue, MD, Atsushi Inoue, MD, Ran Aimoto, MD, Mizuki Aimoto, MD, Yoshiki Terada, MD, PhD, Ki-Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Masayuki Hino, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4347.
https://doi.org/10.1182/blood.V114.22.4347.4347
Published: 2009
Journal Articles

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, MD, PhD, Ran Moriguchi, MD, Hiroshi Kanashima, MD, PhD, Erina Sakamoto, MD, PhD, Dai Momose, MD, Mizuki Aimoto, MD, Shuichirou Okamoto, MD, Eri Wada, MD, Hideo Koh, MD, Takahiko Nakane, MD, Yasunobu Takeoka, MD, Ki- Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Yoshitaka Nakao, MD, PhD, Kensuke Ohta, MD, PhD, Atsuko Mugitani, MD, PhD, Hirofumi Teshima, MD, PhD, Masayuki Hino, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4931.
https://doi.org/10.1182/blood.V112.11.4931.4931
Published: 2008
Journal Articles

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Hongzhang Li, M.D., Hideo Koh, M.D., Takahiko Nakane, M.D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1971.
https://doi.org/10.1182/blood.V110.11.1971.1971
Published: 2007
Journal Articles

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph. D., Kensuke Ohta, M.D., Ph. D., Hideo Koh, M.D., Takahiko Nakane, M.D., Mika Nakamae, M.D., Ph. D., Hiroshi Kanashima, M.D., Ph. D., Kiyoyuki Hagihara, M.D., Ph. D., Erina Sakamoto, M.D., Ph. D., Yoshiki Terada, M.D., Ph. D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph. D., Takahisa Yamane, M.D., Ph. D., Masayuki Hino, M.D., Ph.D
Journal: Blood
Blood (2006) 108 (11): 2885.
https://doi.org/10.1182/blood.V108.11.2885.2885
Published: 2006
Journal Articles

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Hirohisa Nakamae, MD, PhD, Takahisa Yamane, MD, PhD, Hagihara Kiyoyuki, MD., PhD., Yasunobu Takeoka, MD., Erina Sakamoto, MD., PhD., Takahiko Nakane, MD., Mika Nakamae, MD., PhD., Ki-Ryang Koh, MD., PhD., Kensuke Ohta, MD., PhD., Masayuki Hino, MD., PhD.
Journal: Blood
Blood (2005) 106 (11): 1775.
https://doi.org/10.1182/blood.V106.11.1775.1775
Published: 2005